September – 28, 2017, New York – What an incredible month! Sawaya Partners Consumer Healthcare team is pleased to report the announcement and closing of three transactions with an aggregate transaction value of approximately $1.5 Billion. These three announcements emphasize the broad skill set of our team who:

1. Advised Foundation Consumer Healthcare and its two private equity investors, Juggernaut Capital Partners and Kelso, in the signing of a definitive agreement to acquire the Plan B One-Step brand from TEVA.

2. Completed the carve out and sale of the Compeed brand from Johnson & Johnson’s Consumer to HRA Pharma, a portfolio company of Astorg and Goldman Sachs Merchant Banking Division.

3. Completed the sale of WellSpring Pharmaceutical, a portfolio of Sentinel Capital Partners to a new entrant in the industry, the Audax Group.